Superconducting qubit device with crystalline fluoride dielectric layer at the capacitor or junction interface

The fundamental bottleneck in superconducting quantum computing is not the Josephson junction itself — it is the dielectric environment surrounding it. Every transmon qubit requires a shunt capacitor to set the charging-to-Josephson-energy ratio that makes the circuit insensitive to charge noise, and every junction-adjacent surface harbors a thin, disordered oxide layer. Both of these structures are saturated with two-level systems (TLS): quantum mechanical tunneling defects that absorb microwave photons, dephase the qubit, and ultimately limit coherence times. Decades of engineering with amorphous SiO2 and AlOx have incrementally improved coherence, but the TLS problem is intrinsic to amorphous materials — their structural disorder is the source of defects, and no amount of processing optimization fully removes them. The only durable fix is to replace amorphous oxides with a material that is crystalline at deposition temperatures compatible with superconducting device fabrication. This asset, within the metal-fluoride qubit dielectric materials portfolio, covers precisely that substitution: a superconducting quantum device in which a crystalline fluoride from the covered material genus is placed as the dielectric at the shunt capacitor interface and/or as a passivation layer adjacent to the Josephson junction, displacing amorphous oxide. The claim is a use-limited device architecture — the complete qubit device configured with the genus material, not the fluoride composition in isolation. This distinction is strategically significant: the device claim is enforceable against finished qubit hardware vendors regardless of who supplies the raw material, giving it direct commercial reach to the operators and OEMs who build quantum processors. The timing is acute. IBM's published fault-tolerant roadmap targets utility-scale processors between 2026 and 2029, and DARPA's Quantum Benchmarking Initiative is executing procurement downselects in 2025 and 2026. Qubit coherence is a direct gate on that schedule. Any hardware vendor that can demonstrate systematically lower TLS loss at the shunt capacitor — without restructuring junction geometry or superconductor choice — has a differentiating advantage that will be competed for aggressively in this window.

The physics of TLS loss in superconducting qubits is well-characterized: disordered materials contain two-site potentials in which atoms or small groups of atoms can tunnel quantum mechanically between two configurations. When the energy splitting of one of these defects is resonant with the qubit transition frequency (typically 4-8 GHz for transmons), it absorbs photon energy, contributing to dielectric loss. The relevant figure of merit is the inverse quality factor of the capacitor, 1/Qi, which enters directly into the qubit energy relaxation time T1 = Qi / (2πf). Reducing TLS density by replacing amorphous oxides with well-ordered crystalline materials is predicted to reduce 1/Qi by suppressing the structural configurations that host two-site potentials in the first place. A secondary benefit is the reduction of so-called participation ratio: in a parallel-plate or interdigitated capacitor geometry, the fraction of the total electric field energy that resides within the dielectric layer is the participation ratio, and a crystalline layer with lower intrinsic loss density yields lower effective loss even at the same layer thickness. The device architecture covers deposition of a crystalline fluoride genus member at thicknesses from 2 to 200 nm onto superconducting electrode materials that include niobium, tantalum, aluminum, and titanium nitride — the four leading electrode chemistries in the contemporary qubit hardware landscape. Deposition is specified across atomic layer deposition (ALD), molecular beam epitaxy (MBE), and physical vapor deposition (PVD), which encompasses virtually all thin-film techniques with the precision and conformality needed for sub-10-nm junction-adjacent layers. Device operation is specified below 100 mK, consistent with dilution refrigerator operation. The combination of material genus, deposition methods, electrode substrates, layer-thickness range, and operating condition defines a genuinely broad device claim that does not depend on a single material composition or deposition tool. On the computational side, the theoretical basis for the dielectric improvement is grounded in participation-ratio analysis detailed in the specification background — a well-established framework in the qubit community that maps field energy distribution in a capacitor geometry to loss contributions from each interface and dielectric layer. A crystalline fluoride layer with ordered atomic positions and a reduced defect density is predicted to lower both the intrinsic loss tangent of the dielectric and, through permittivity engineering, can also affect the fraction of field energy in the layer. The genus materials that populate the metal-fluoride qubit dielectric materials portfolio were identified through a systematic computational screen and have been subjected to independent computational validation under that portfolio's broader methodology — including multi-potential phonon stability assessment — but the device architecture claim itself is grounded in the established physics of participation-ratio loss reduction and the known relationship between crystallinity and TLS suppression. The critical open gate for this specific device asset is experimental: measured qubit coherence time T1 and internal quality factor Qi for devices fabricated with the genus fluoride, compared against matched amorphous SiO2 and AlOx control devices. Additionally, direct measurement of TLS density in the fluoride layer via spectroscopy or loss tangent extraction at millikelvin temperatures remains to be completed. These are standard characterization experiments in the qubit community, but they require access to dilution refrigerator infrastructure and device fabrication capability. Until these measurements exist, the participation-ratio argument provides the theoretical motivation but not the experimental proof of claim.

The addressable market for this device architecture is the capital expenditure on superconducting quantum processor hardware and the associated IP licensing position that enables royalty capture against that spend. The superconducting quantum computing hardware market, across processor modules, dilution refrigerators, and control electronics, is estimated at roughly $1 to $2 billion in annual addressable spend through the end of the decade, growing as fault-tolerant systems require higher qubit counts and more stringent coherence specifications. This estimate should be understood as approximate — the market is early-stage and projections from independent analysts vary — but the directional logic is sound: fault-tolerant quantum computing requires error rates below threshold, and qubit coherence is a primary lever on that error budget. The licensing logic for a device architecture claim of this type is straightforward. A use-limited device claim that reads on any superconducting qubit processor incorporating the genus dielectric at the shunt capacitor or junction interface is enforceable against the OEM, not just the materials supplier. This is high-leverage IP because the royalty base is the processor unit or the processor development contract, not the commodity fluoride deposition run. The customers in the frame — IBM Quantum, Google Quantum AI, Rigetti Computing, and the AWS Center for Quantum Computing — are collectively responsible for the majority of transmon-based hardware development globally and are actively racing toward fault-tolerant milestones on published timelines that converge in the 2026-2029 period. Royalty rates for enabling device architecture IP in adjacent semiconductor technology have historically run in the low single-digit percentage of device value or low tens of dollars per unit for component-level technology. For quantum processors that currently cost in the range of millions of dollars per cryostat system, even a very small royalty rate against development program revenue represents substantial licensing income. Alternatively, an outright acquisition of the device claim as part of the broader portfolio provides a defensive position for any hardware vendor: owning the claim prevents competitors from using it offensively and ensures freedom to practice the architecture as crystalline fluoride dielectrics move from research to production processes.

reduced dielectric loss for fixed geometry vs amorphous SiO2/AlOx; high-leverage low-mass component of fault-tolerant hardware spend

use-limited engineered device, not a composition-of-matter; FTO leg 1

The natural acquirers or licensees for this device architecture claim are the major superconducting quantum processor developers: IBM Quantum, Google Quantum AI, Rigetti Computing, and the AWS Center for Quantum Computing are the specifically identified customers, and collectively they represent the principal hardware development programs that will need to address TLS loss systematically as they scale toward fault-tolerant processor configurations. For any of these organizations, acquiring or licensing a broad device-use claim on crystalline fluoride dielectrics at the qubit capacitor interface serves two purposes simultaneously: it provides freedom to practice the architecture without infringement exposure, and it prevents competitors from asserting the same claim offensively. In a market where qubit coherence is a key differentiator and patent portfolios around qubit architecture are actively being assembled, defensive acquisition of a well-structured device claim is a rational IP strategy. Beyond the major platform developers, the claim is also relevant to defense and government quantum programs — DARPA QBI and related initiatives that are funding hardware development through 2026 downselects — and to the emerging class of quantum hardware suppliers who fabricate qubit modules for sale or lease rather than operating them directly. A material supplier with ALD or MBE capability who develops a qualified fluoride deposition process for qubit foundry use would also have strong motivation to secure or partner around the device claim, since the claim reads on the finished device regardless of the supply chain structure. The asset is best positioned as part of a portfolio transaction covering the full metal-fluoride qubit dielectric materials family, where the device-use claim provides the commercial enforcement hook and the companion composition and method assets provide layered depth.

The principal risk is the open experimental gate: this asset is theoretically well-grounded and architecturally broad, but it lacks the measured T1 and Qi data that would make it a proven, commercially ready technology. A sophisticated buyer will discount the claim accordingly — the question is whether the discount reflects the true experimental risk, which in this case is primarily execution risk (can the fluoride be deposited in a compatible process flow?) rather than physics risk (the participation-ratio argument for loss reduction is well-established). A second risk is prosecution: the device-use claim must survive examination against the body of crystalline dielectric qubit literature, which has grown substantially since 2020. If the examiner construes the fluoride genus too narrowly or requires exemplification of specific genus members with measured qubit data, prosecution could narrow the claim scope before grant. The roadmap to de-risk the asset follows naturally from the validation gates. Near-term, the priority is integrating a genus fluoride into a standard Nb or Ta qubit process flow at the ALD level — this is a focused materials-integration experiment, not a full device development program. Loss tangent measurements of fluoride films at millikelvin temperatures in superconducting coplanar resonators provide rapid feedback on TLS density without requiring full qubit fabrication. If resonator data shows loss tangent improvement over amorphous oxide controls, that data directly supports both prosecution arguments and commercial conversations. Full transmon T1 characterization follows as the confirmatory experiment. The entire de-risking sequence is achievable within a 12-18 month timeline by a team with access to qubit fabrication and cryogenic characterization infrastructure, making this a well-defined and bounded development risk rather than an open-ended research program.